The aims of our study were to compare the ability of human breast cancer cells expressing high and low levels of COX-2 to form vascular channels on three-dimensional matrigel cultures, and to assess the effect of therapeutically targeting COX-2 in vitro and in vivo on VM. This evidence concerns the gene PTGS2 and breast cancer.